Adicet Bio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
Adicet Bio, Inc. (ACET) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number of 1.69 million shares as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber · last filed 2026-08-05
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 1.69M shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 1.58M shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 763.46K shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number 17.54M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number |
|---|---|
| 2026-06-30 | 1.69M shares 10-Q · filed 2026-08-05 |
| 2026-03-31 | 1.58M shares 10-Q · filed 2026-05-13 |
| 2025-12-31 | 763.46K shares 10-K · filed 2026-03-12 |
| 2025-09-30 | 17.54M shares 10-Q · filed 2025-11-05 |
| 2025-06-30 | 18.18M shares 10-Q · filed 2025-08-07 |
| 2025-03-31 | 18.37M shares 10-Q · filed 2025-05-06 |
| 2024-12-31 | 14.97M shares 10-K · filed 2025-03-06 |
| 2024-09-30 | 15.70M shares 10-Q · filed 2024-11-06 |
| 2024-06-30 | 16.15M shares 10-Q · filed 2024-08-13 |
| 2024-03-31 | 12.71M shares 10-Q · filed 2024-05-14 |
| 2023-12-31 | 9.38M shares 10-K · filed 2024-03-19 |
| 2023-09-30 | 9.75M shares 10-Q · filed 2023-11-08 |
| 2023-06-30 | 8.34M shares 10-Q · filed 2023-08-09 |
| 2023-03-31 | 8.14M shares 10-Q · filed 2023-05-09 |
| 2022-12-31 | 6.20M shares 10-K · filed 2023-03-15 |
| 2022-09-30 | 5.86M shares 10-Q · filed 2022-11-08 |
| 2022-06-30 | 5.75M shares 10-Q · filed 2022-08-10 |
| 2022-03-31 | 5.38M shares 10-Q · filed 2022-05-12 |
| 2021-12-31 | 3.88M shares 10-K · filed 2022-03-15 |
| 2021-09-30 | 4.28M shares 10-Q · filed 2021-11-10 |
| 2021-06-30 | 4.44M shares 10-Q · filed 2021-08-12 |
| 2021-03-31 | 4.77M shares 10-Q · filed 2021-05-17 |
| 2020-12-31 | 3.71M shares 10-K · filed 2021-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |